UNSPSC 85502527: Restriction of left common carotid artery with bioactive intraluminal device, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of left common carotid artery with bioactive intraluminal device, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03VJ0BZ

UNSPSC 85502527 Restriction of left common carotid artery with bioactive intraluminal device, open approach (Commodity) bears a clinical medical procedure code designation that does not align with the state and local procurement activity presently tagged under it. The recent opportunities associated with this code span health service administration, occupational medical surveillance, pharmacy benefit management, and temporary clinical staffing — none of which involve carotid artery restriction procedures or implantable devices. The issuing bodies across these solicitations include county governments (Collier County, Harris County, Santa Clara County), municipalities (City of Phoenix, City of Long Beach), and state departments (Washington State Department of Transportation), collectively sourcing administration and staffing support rather than surgical interventions.

The geographic spread of recent activity spans Arizona, California, Florida, Texas, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office RFP 26001 for independent medical evaluation services (proposals due October 16, 2026) supporting disability benefit determinations for public safety personnel; the Washington State Department of Transportation RFP 20260825 for occupational medical surveillance across 14 ferry system locations statewide (proposals due October 9, 2026 with pre-bid August 31, 2026); and the County of Santa Clara Health System multiple-award qualification pool for temporary health professional staffing across thirteen ancillary clinical categories (proposals due October 7, 2026). The code shows no relevant recent activity aligned with its nominal medical device or surgical procedure scope.